Please assess the completion status of the following clinical trial:

Trial Title: Succinylcholine or Rocuronium for Rigid Bronchoscopy Under General Anesthesia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients scheduled for an interventional rigid bronchoscopy under general anesthesia~Exclusion Criteria:~* pregnant woman or woman of childbearing age,~* morbid obesity,~* drug allergy,contra-indication to succinylcholine, rocuronium, sugammadex, propofol, remifentanil,~* history of central neurological or brain damage,~* psychotropic treatment,~* pacemaker,~* renal failure,~* disease of the neuromuscular junction.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- succinylcholine (Type: ACTIVE_COMPARATOR): Succinylcholine 1 mg/kg and a second dose if necessary.
- Rocuronium (Type: EXPERIMENTAL): rocuronium 0,9 mg/kg with additional boluses of 0,3 mg/kg f necessary

Based on this trial design, predict the completion outcome and termination type (if applicable).